AU7743500A - Methods and compositions relating to novel sodium channel $(b)1a subunits - Google Patents

Methods and compositions relating to novel sodium channel $(b)1a subunits

Info

Publication number
AU7743500A
AU7743500A AU77435/00A AU7743500A AU7743500A AU 7743500 A AU7743500 A AU 7743500A AU 77435/00 A AU77435/00 A AU 77435/00A AU 7743500 A AU7743500 A AU 7743500A AU 7743500 A AU7743500 A AU 7743500A
Authority
AU
Australia
Prior art keywords
subunits
methods
sodium channel
compositions relating
novel sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77435/00A
Inventor
Michael D'andrea
Kathryn E. Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU7743500A publication Critical patent/AU7743500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU77435/00A 1999-09-30 2000-09-29 Methods and compositions relating to novel sodium channel $(b)1a subunits Abandoned AU7743500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15683799P 1999-09-30 1999-09-30
US60/156837 1999-09-30
PCT/US2000/027034 WO2001023570A2 (en) 1999-09-30 2000-09-29 Methods and compositions relating to sodium channel beta-1a subunits

Publications (1)

Publication Number Publication Date
AU7743500A true AU7743500A (en) 2001-04-30

Family

ID=22561303

Family Applications (2)

Application Number Title Priority Date Filing Date
AU77435/00A Abandoned AU7743500A (en) 1999-09-30 2000-09-29 Methods and compositions relating to novel sodium channel $(b)1a subunits
AU77461/00A Abandoned AU7746100A (en) 1999-09-30 2000-09-29 Methods and compositions relating to sodium channel beta1a subunits

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU77461/00A Abandoned AU7746100A (en) 1999-09-30 2000-09-29 Methods and compositions relating to sodium channel beta1a subunits

Country Status (5)

Country Link
EP (1) EP1216300A1 (en)
JP (1) JP2003510079A (en)
AU (2) AU7743500A (en)
CA (1) CA2381771A1 (en)
WO (2) WO2001023571A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1287134T3 (en) 2000-06-07 2007-12-03 Ortho Mcneil Pharm Inc The human voltage-gated sodium channel 1A subunit and methods for its use
PT1458386E (en) 2001-12-27 2007-06-04 Ortho Mcneil Pharm Inc Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
EP1336847B1 (en) * 2002-02-14 2007-12-12 Biofrontera Pharmaceuticals AG Cathepsin Y inhibitors for the development of a medicament for the treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371976A1 (en) * 1999-04-15 2000-10-26 Peter Cox A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
AU5010900A (en) * 1999-05-14 2000-12-05 Millennium Pharmaceuticals, Inc. Gene encoding a sodium channel beta-3 subunit protein

Also Published As

Publication number Publication date
WO2001023571A1 (en) 2001-04-05
AU7746100A (en) 2001-04-30
EP1216300A1 (en) 2002-06-26
WO2001023570A2 (en) 2001-04-05
CA2381771A1 (en) 2001-04-05
WO2001023570A3 (en) 2001-10-25
JP2003510079A (en) 2003-03-18

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU7389300A (en) Methods of administration of glycopyrrolate compositions
HUP0201613A3 (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators and pharmaceutical compositions containing them
AU2002210529A1 (en) Shear gel compositions
AU2115301A (en) Dental compositions
AU4976400A (en) Glass composition
AU3671099A (en) Methods and compositions pertaining to pd-loops
AU3913800A (en) Novel antioxidant formulations and methods for using them
AU8053898A (en) Immunogenic compositions
AU6618900A (en) Compositions useful as desiccants and methods relating thereto
AU4428000A (en) Pulse-delivery oral compositions
AUPP589398A0 (en) Immunogenic compositions and uses thereof
AU4996100A (en) (s,r) formoterol methods and compositions
AU2001241159A1 (en) Silicone gel composition
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU3000599A (en) Moisturizing compositions
AU5085300A (en) Compositions
AU7743500A (en) Methods and compositions relating to novel sodium channel $(b)1a subunits
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU7100500A (en) Non combustible nonaqueous compositions
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU5054099A (en) Non-aqueous anthelmintic composition
AU2012101A (en) Veterinary compositions
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase